Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN567620 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Mitogen-Activated Protein Kinase 3 (MAPK3) antibody
- Antibody type
- Monoclonal
- Description
- Protein-G affinity chromatography
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- AT1A2
- Vial size
- 50 μL
Submitted references Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.
Differential regulation and properties of MAPKs.
The MEK/ERK cascade: from signaling specificity to diverse functions.
Roberts PJ, Der CJ
Oncogene 2007 May 14;26(22):3291-310
Oncogene 2007 May 14;26(22):3291-310
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.
Meloche S, Pouysségur J
Oncogene 2007 May 14;26(22):3227-39
Oncogene 2007 May 14;26(22):3227-39
Differential regulation and properties of MAPKs.
Raman M, Chen W, Cobb MH
Oncogene 2007 May 14;26(22):3100-12
Oncogene 2007 May 14;26(22):3100-12
The MEK/ERK cascade: from signaling specificity to diverse functions.
Shaul YD, Seger R
Biochimica et biophysica acta 2007 Aug;1773(8):1213-26
Biochimica et biophysica acta 2007 Aug;1773(8):1213-26
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Image(s): Immunofluorescence